1. Volume 66, Issue 2, Pages 330-336 (August 2014)
Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study 
Robert J. van Soest, Ellen S. de Morrée, Liji Shen, Ian F. Tannock, Mario A. Eisenberger, Ronald de Wit 
European Urology 
Volume 66, Issue 2, Pages (August 2014)
DOI: /j.eururo
Copyright © 2013 European Association of Urology Terms and Conditions

2. Fig. 1
Kaplan-Meier estimates of overall survival for the docetaxel (75mg/m2 every 3 wk) arm and the mitoxantrone (every 3 wk) arm in (A) the Gleason score 7–10 subgroup and (B) the Gleason score 2–6 subgroup.
European Urology  , DOI: ( /j.eururo )
Copyright © 2013 European Association of Urology Terms and Conditions